NGM Biopharmaceuticals, Inc.
COMBINATION THERAPY WITH GLUCAGON RECEPTOR ANTAGONISTS
Last updated:
Abstract:
The present disclosure provides methods comprising a glucagon receptor antagonist in combination with an immunotherapeutic agent for treatment of disease.
Status:
Application
Type:
Utility
Filling date:
26 Jul 2019
Issue date:
13 Feb 2020